|Events|May 1, 2023
Compliance Congress for Specialty Products (9/19-9/21)
September 19-21, 2023 | Boston, MA
Reunite with Your Community to Overcome the Unique Risks & Challenges Associated with Complex Therapeutics
Bridge the gap between niche markets and industry standards to accelerate towards a solution catered exclusively for specialty pharmaceutical companies focuses on rare, ultra-rare and orphan diseases.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Pharmaceutical Executive Daily: FDA Approves Hernexeos
2
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
3
FDA Approves Hernexeos Under National Priority Voucher Program
4
FDA Approves Dupixent as First Treatment for Allergic Fungal Rhinosinusitis in Adults and Children
5